An analysis of totally implantable central venous port system infections in an urban tertiary referral center

References

• Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92(4):706–12.
   PubMed Web of Science ®Google Scholar
• Mori Y, Nagayama S, Kawamura J-I, Hasegawa S, Tanaka E, Okabe H, Takeuchi M, Sonobe M, Matsumoto S, Kanai M, et al. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. Int J Clin Oncol. 2016;21(3):474–82.
   PubMed Web of Science ®Google Scholar
• Narducci F, Jean-Laurent M, Boulanger L, El Bédoui S, Mallet Y, Houpeau JL, Hamdani A, Penel N, Fournier C. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre. Eur J Surg Oncol. 2011;37(10):913–8.
   PubMed Web of Science ®Google Scholar
• Fischer L, Knebel P, Schröder S, Bruckner T, Diener MK, Hennes R, Buhl K, Schmied B, Seiler CM. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients. Ann Surg Oncol. 2008;15(4):1124–9.
   PubMed Web of Science ®Google Scholar
• Bekçibaşi M, Dayan S, Aslan E, Kortak MZ, Hoşoğlu S. Risk factors for central venous catheter-related bloodstream infections. Infez Med. 2019;27(3):258–65.
   PubMedGoogle Scholar
• Sousa B, Furlanetto J, Hutka M, Gouveia P, Wuerstlein R, Mariz JM, Pinto D, Cardoso F, ESMO Guidelines Committee. Central venous access in oncology: ESMO clinical practice guidelines. Ann Oncol. 2015;26 Suppl 5:152–68.
   Google Scholar
• Viale P, Stefani S. Vascular catheter-associated infections: a microbiological and therapeutic update. J Chemother. 2006;18(3):235–49.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.
   PubMed Web of Science ®Google Scholar
• Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, Ruhnke M, Penack O, Salwender HJ, Wolf HH, et al. 2015. Guideline of the German Society of Hematology and Oncology. [cited 2020 Mar 11]. Available  from: https://www.onkopedia.com/de/onkopedia/guidelines/zvk-infektionen/@@guideline/html/index.html
   Google Scholar
• Tabatabaie O, Kasumova GG, Eskander MF, Critchlow JF, Tawa NE, Tseng JF. Totally implantable venous access devices: a review of complications and management strategies. Am J Clin Oncol. 2017;40(1):94–105.
   PubMed Web of Science ®Google Scholar
• Rijnders BJ, Peetermans WE, Verwaest C, Wilmer A, Van Wijngaerden E. Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med. 2004;30(6):1073–80.
   PubMed Web of Science ®Google Scholar
• Bustos C, Aguinaga A, Carmona-Torre F, Del Pozo JL. Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections. Infect Drug Resist. 2014;18(7):25–35.
   Google Scholar
• Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, et al. The third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)). JAMA. 2016;315(8):801–10.
   PubMed Web of Science ®Google Scholar
• Shim J, Seo T-S, Song MG, Cha I-H, Kim JS, Choi CW, Seo JH, Oh SC. Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J Radiol. 2014;15(4):494–500.
   PubMed Web of Science ®Google Scholar
• Jung N, Rieg S. Essentials in the management of S. aureus bloodstream infection . Infection. 2018;46(4):441–2.
   PubMed Web of Science ®Google Scholar
• Mellinghoff SC, Cornely OA, Jung N. Essentials in Candida bloodstream infection. Infection. 2018;46(6):897–9.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients . Clin Microbiol Infect. 2012;18 Suppl 7:19–37.
   PubMed Web of Science ®Google Scholar
• Blanco-Guzman MO. Implanted vascular access device options: a focused review on safety and outcomes. Transfusion. 2018;58 Suppl 1:558–68.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Diagn Microbiol Infect Dis. 2009;63(2):208–12.
   PubMed Web of Science ®Google Scholar
• Viale P, Pagani L, Petrosillo N, Signorini L, Colombini P, Macri G, Cristini F, Gattuso G, Carosi G, Italian Hospital and HIV Infection Group. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother. 2003;15(2):152–6.
   PubMed Web of Science ®Google Scholar
• Justo JA, Bookstaver PB. Antibiotic lock therapy: review of technique and logistical challenges. Infect Drug Resist. 2014;7:343–63.
   PubMed Web of Science ®Google Scholar
• Maier S, Eckmann C, Kramer A. Perioperative Antibiotikaprophylaxe: ein update. Krankenhhyg Up2date. 2015;10(02):105–12.
   Google Scholar
• Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch Institut. Prävention postoperativer Wundinfektionen. Bundesgesundheitsbl. 2018;61:448–73.
   Google Scholar
• Pinelli F, Cecero E, Degl'Innocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M. Infection of totally implantable venous access devices: a review of the literature. J Vasc Access. 2018;19(3):230–42.
   PubMed Web of Science ®Google Scholar
• Bamba R, Lorenz JM, Lale AJ, Funaki BS, Zangan SM. Clinical predictors of port infections within the first 30 days of placement. J Vasc Interv Radiol. 2014;25(3):419–23.
   PubMed Web of Science ®Google Scholar
• Berrueco R, Rives S, Català A, Toll T, Gene A, Ruiz A, Badosa R, Claramonte MA, Estella J, Urrea M. Prospective surveillance study of blood stream infections associated with central venous access devices (port-type) in children with acute leukemia: an intervention programm. J Pediatr Hematol Oncol. 2013;35(5):e194–9.
   PubMed Web of Science ®Google Scholar
• Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med. 2005;142(6):451–66.
   PubMed Web of Science ®Google Scholar
• Kato H, Yoshimura Y, Suido Y, Ide K, Sugiyama Y, Matsuno K, Nakajima H. Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection. Infection. 2018;46(5):635–40.
   PubMed Web of Science ®Google Scholar
• Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch Institut. Hinweise zur Blutkulturdiagnostik. Bundesgesundheitsbl. 2017;60:216–30.
   Google Scholar
• Lee GJ, Hong SH, Roh SY, Park SR, Lee MA, Chun HG, Hong YS, Kang JH, Kim SI, Kim YJ, et al. A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infection . Cancer Res Treat. 2014;46(3):250–60.
   PubMed Web of Science ®Google Scholar
• Lebeaux D, Larroque B, Gellen-Dautremer J, Leflon-Guibout V, Dreyer C, Bialek S, Froissart A, Hentic O, Tessier C, Ruimy R, et al. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine. 2012;91(6):309–18.
   PubMed Web of Science ®Google Scholar
• Tatsuno K, Ikeda M, Wakabayashi Y, Yanagimoto S, Okugawa S, Moriya K. Clinical features of bloodstream infections associated with peripheral versus central venous catheters. Infect Dis Ther. 2019;8(3):343–52.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: an analysis of 24.179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–17.
   PubMed Web of Science ®Google Scholar
• Resistance Surveillance Project of the British Society for Antimicrobial Chemotherapy, Bacteraemia Data; 2017 [cited 2020 Mar 11]. Available from: http://www.bsacsurv.org/reports/
   Google Scholar
• Antibiotika Resistenz Surveillance, Robert Koch Institut, Berlin/Germany; 2017 [cited 2020 Mar 11]. Available from: https://ars.rki.de/Content/Database/ResistanceOverview.aspx
   Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe – annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2017; [cited 2020 Mar 11]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/AMR%202017_Cover%2BInner-web_v3.pdf
   Google Scholar
• Megged O, Shalit I, Yaniv I, Fisher S, Livni G, Levy I. Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children. Eur J Clin Microbiol Infect Dis. 2010;29(2):157–61.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, García Cenoz M, Hernáez S, Martínez A, Serrera A, Aguinaga A, Alonso M, Leiva J. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. Int J Antimicrob Agents. 2009;34(5):482–5.
   PubMed Web of Science ®Google Scholar
• Vassallo M, Genillier P-L, Dunais B, Kaphan R, Saudes L, Duval Y, Rolland F, Jullien V, Weiss N, Blanchouin E, et al. Short-course daptomycin lock and systemic therapy for catheter-related bloodstream infections: a retrospective cohort study in cancer patients with surgically implanted devices. J Chemother. 2017;29(4):232–7.
   PubMed Web of Science ®Google Scholar
• Soman R, Gupta N, Suthar M, Kothari J, Almeida A, Shetty A, et al. Antibiotic lock therapy in the era of Gram-negative resistance. J Assoc Physicians India. 2015;63(1):18–21.
   PubMedGoogle Scholar
• Tsai H-C, Huang L-M, Chang L-Y, Lee P-I, Chen J-M, Shao P-L, Hsueh P-R, Sheng W-H, Chang Y-C, Lu C-Y, et al. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy. J Microbiol Immunol Infect. 2015;48(6):639–46.
   PubMedGoogle Scholar
• European Commitee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MIC’s and zone diameters. Version 10.0, valid from 2020-01-01. [cited 2020 Mar 11]. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_10.0_Breakpoint_Tables.pdf
   Google Scholar
• Rubinstein E, Keynan Y. Vancomycin revisited – 60 years later. Front Public Health. 2014;2:217.
   PubMedGoogle Scholar
• Hall Snyder AD, Vidaillac C, Rose W, McRoberts JP, Rybak MJ. Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis in a novel in vitro PK/PD model of bacterial biofilm. Infect Dis Ther. 2015;4(1):51–65.
   PubMed Web of Science ®Google Scholar
• Cui J, Liang Z, Mo Z, Zhang J. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China. Antimicrob Resist Infect Control. 2019;8:65.
   PubMed Web of Science ®Google Scholar
• Gkentzi D, Kolyva S, Spiliopoulou I, Marangos M, Dimitriou G. Treatment options for persistent coagulase negative staphylococcal bacteremia in neonates. Curr Pediatr Rev. 2016;12(3):199–208.
   PubMed Web of Science ®Google Scholar
• Zeneli A, Mezzadri S, Bertozzi L, Resi D, Golinucci M, Dodi S, Prati E. A surveillance system model for central line-associated bloodstream infections (CLABSI) coordinated at the regional level: a pilot feasibility study. Infez Med. 2017;25(2):108–15.
   PubMedGoogle Scholar